Harvard's Dr. David Ludwig addresses whether GLP1 weight loss drugs like semaglutide, Wegovy & Ozempic should replace keto and lowcarb diets for obesity, even in children. Or can lowcarb diets complement drug treatments to reduce costs and longterm health risks and provide a path to lifelong metabolic health?

Dr. Ludwig's new paper on the social justice implications of this issue is coauthored by Dr. Jens J. Holst, who has been credited with discovering the hormone GLP1.

The GLP1 medications semaglutide, Wegovy & Ozempic have taken the weight loss community by storm. They are even recommended for children and adolescents with obesity. But what are the longterm consequences of such widespread use, and why has the medical community seemingly abandoned dietary changes and behavioral support for medications and surgery? And what about the impact on longterm metabolic health and on questions of social justice?

Dr. David Ludwig is a Harvard researcher and endocrinologist. We discuss how the mechanisms of these medications are similar to those of lowcarb diets and how Dr. Ludwig feels there's room for shortterm use of medications to complement lowcarb nutrition for weight loss and improved metabolic health.

A key question we ask ourselves at Metabolic Mind is what impact GLP1 drugs will have on brain function. They do not have the benefit that ketogenic diets do of leading to producing ketones, an efficient fuel for the brain, which appears to be a key mechanism of action of keto in treating serious mental illness. More research is needed to address this important topic.

Experts featured in this video:

David Ludwig, MD PhD
https://www.hsph.harvard.edu/profile/...
Twitter:  / davidludwigmd  

Jens Holst MD, DMSc
https://bmi.ku.dk/english/Staff/?pure...

Paper referenced in this video:
Childhood Obesity at the Crossroads of Science and Social Justice
https://jamanetwork.com/journals/jama...

Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.

Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/


About us:
Metabolic Mind™ is a nonprofit initiative incubated by Baszucki Group. Our mission is to provide education and resources in the emerging field of metabolic psychiatry, including ketogenic interventions for mental disorders.

Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a providerpatient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

#MetabolicMind
#KetoForMentalHealth
#MetabolicPsychiatry
#GLP1
#Ozempic
#Wegovy
#Semaglutide
#BipolarTreatment
#MetabolicNeuroscience
#KetogenicMetabolicTherapy
#NutritionalKetosis
#MentalIllnessTreatment
#MentalHealthIsMetabolicHealth
#obesity
#socialjustice